247 related articles for article (PubMed ID: 30522474)
1. Investigation and management of moderate to severe inpatient hyponatraemia in an Australian tertiary hospital.
Berkman K; Haigh K; Li L; Lockett J; Dimeski G; Russell A; Inder WJ
BMC Endocr Disord; 2018 Dec; 18(1):93. PubMed ID: 30522474
[TBL] [Abstract][Full Text] [Related]
2. Urea treatment in fluid restriction-refractory hyponatraemia.
Lockett J; Berkman KE; Dimeski G; Russell AW; Inder WJ
Clin Endocrinol (Oxf); 2019 Apr; 90(4):630-636. PubMed ID: 30614552
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of hyponatraemia in hospitalised patients.
Reddy P; Mooradian AD
Int J Clin Pract; 2009 Oct; 63(10):1494-508. PubMed ID: 19769706
[TBL] [Abstract][Full Text] [Related]
4. Multicentre study of investigation and management of inpatient hyponatraemia in the UK.
Tzoulis P; Evans R; Falinska A; Barnard M; Tan T; Woolman E; Leyland R; Martin N; Edwards R; Scott R; Gurazada K; Parsons M; Nair D; Khoo B; Bouloux PM
Postgrad Med J; 2014 Dec; 90(1070):694-8. PubMed ID: 25398584
[TBL] [Abstract][Full Text] [Related]
5. Investigation and management of severe hyponatraemia in a hospital setting.
Huda MS; Boyd A; Skagen K; Wile D; van Heyningen C; Watson I; Wong S; Gill G
Postgrad Med J; 2006 Mar; 82(965):216-9. PubMed ID: 16517805
[TBL] [Abstract][Full Text] [Related]
6. Osmotic demyelination syndrome following slow correction of hyponatraemia.
Saunders I; Williams DM; Ruslan AM; Min T
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34373247
[TBL] [Abstract][Full Text] [Related]
7. The suspect - SIADH.
Tee K; Dang J
Aust Fam Physician; 2017 Sep; 46(9):677-680. PubMed ID: 28892600
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study.
Krummel T; Prinz E; Metten MA; Borni-Duval C; Bazin-Kara D; Charlin E; Lessinger JM; Hannedouche T
BMC Nephrol; 2016 Oct; 17(1):159. PubMed ID: 27770791
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of hyponatraemia in neurosurgical patients.
Cuesta M; Hannon MJ; Thompson CJ
Endocrinol Nutr; 2016 May; 63(5):230-8. PubMed ID: 26965574
[TBL] [Abstract][Full Text] [Related]
10. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis.
Humayun MA; Cranston IC
BMC Endocr Disord; 2017 Nov; 17(1):69. PubMed ID: 29110656
[TBL] [Abstract][Full Text] [Related]
11. Lack of laboratory assessment of severe hyponatraemia is associated with detrimental clinical outcomes in hospitalised patients.
Whyte M; Down C; Miell J; Crook M
Int J Clin Pract; 2009 Oct; 63(10):1451-5. PubMed ID: 19769701
[TBL] [Abstract][Full Text] [Related]
12. Rapid correction of hyponatraemia with urea may protect against brain damage in rats.
Van Reeth O; Decaux G
Clin Sci (Lond); 1989 Sep; 77(3):351-5. PubMed ID: 2805597
[TBL] [Abstract][Full Text] [Related]
13. Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): design and implementation of an open-label randomised trial.
Warren AM; Grossmann M; Hoermann R; Zajac JD; Russell N
Trials; 2022 Apr; 23(1):335. PubMed ID: 35449020
[TBL] [Abstract][Full Text] [Related]
14. Urea for hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion.
Woudstra J; de Boer MP; Hempenius L; van Roon EN
Neth J Med; 2020 Apr; 78(3):125-131. PubMed ID: 32332187
[TBL] [Abstract][Full Text] [Related]
15. Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
Velez JC; Dopson SJ; Sanders DS; Delay TA; Arthur JM
Nephrol Dial Transplant; 2010 May; 25(5):1524-31. PubMed ID: 20064953
[TBL] [Abstract][Full Text] [Related]
16. Quality and cost considerations in hyponatraemic patients needing hospitalisation.
Althaus AE; Krapf R
Swiss Med Wkly; 2018 Sep; 148():w14662. PubMed ID: 30378638
[TBL] [Abstract][Full Text] [Related]
17. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
[TBL] [Abstract][Full Text] [Related]
18. From renal salt wasting to SIADH.
Chua TH; Ly M; Thillainadesan S; Wynne K
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29437746
[TBL] [Abstract][Full Text] [Related]
19. Hyponatremia and antidiuresis syndrome.
Vantyghem MC; Balavoine AS; Wémeau JL; Douillard C
Ann Endocrinol (Paris); 2011 Dec; 72(6):500-12. PubMed ID: 22119069
[TBL] [Abstract][Full Text] [Related]
20. Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care.
Tzoulis P; Carr H; Bagkeris E; Bouloux PM
Endocrine; 2017 Feb; 55(2):539-546. PubMed ID: 27837439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
